Drug execs face Capitol Hill questions on vaccine supply

Drug execs face Capitol Hill questions on vaccine supply

FILE – In this Feb. 12, 2021, file photo, scripps health official draws from a vile of the COVID-19 vaccine prior to administering it at their new drive-thru vaccination site at the Del Mar Fairgrounds in Del Mar, Calif. Executives from the major COVID-19 vaccine producers are set Tuesday, Feb. 23, to answer questions from Congress about expanding the supply of shots needed to curb the pandemic that has killed more than 500,000 Americans. (Nelvin C. Cepeda/The San Diego Union-Tribune via AP, Pool, File) WASHINGTON (AP) — Executives from the major COVID-19 vaccine producers are set to answer questions from Congress on Tuesday about expanding the supply of shots needed to curb the pandemic that has killed more than 500,000 Americans. The hearing comes as U.S. vaccinations continue to accelerate after a sluggish start and recent disruptions caused by winter weather. But state health officials say demand for inoculations still vastly outstrips the limited weekly shipments provided by the federal government. The Energy and Commerce Committee panel will hear from the five companies with contracts to supply COVID-19 shots to …
More on: www.yourcentralvalley.com